|Bid||54.6300 x 600|
|Ask||54.6700 x 500|
|Day's Range||54.5600 - 54.7760|
|52 Week Range||49.1500 - 59.5700|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.40%|
Waiting for a bear market may seem like waiting for Godot—it’s been 3,297 days since the last bear market ended on March 9, 2009. Ramsey points out that foreign stocks in the MSCI EAFE index have been lagging the U.S. market this year, and they now trade at 26% discount to the MSCI USA index based on “normalized” price/earnings ratios (which smooth out the volatility in earnings over multi-year periods). The EAFE traded at the same discount in May 2010—the start of an “epic phase of underperformance” compared with the U.S. market, he says in a recent blog post.
CLS Investments' Rusty Vanneman offers ETF picks for investors with a globally balanced portfolio to enhance potential returns.
Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? In December 2017, Teva Pharmaceutical Industries (TEVA) laid out a detailed restructuring plan for the company to turn around its ailing business due to a number of challenges it’s facing.
In August 2017, the FDA approved Teva Pharmaceutical's (TEVA) Austedo for the treatment of adult individuals with tardive dyskinesia.
Value stocks in the United States are scuffling against broader benchmarks and growth stocks. While ex-US developed markets value stocks are also trailing relevant benchmarks, the value factor is performing ...